MedPage Today (11/13, George) reports a study found that “children whose dads took valproate up to 3 months before conception were more likely to have neurodevelopmental disorders.” Researchers observed that “compared with children whose fathers took lamotrigine or levetiracetam, kids with fathers exposed to valproate had a higher risk of a neurodevelopmental disorder diagnosis up to age 12 years.” They noted that “congenital malformation risk did not differ between exposure groups.” The study was published in JAMA Network Open.
Related Links:
— MedPage Today (requires login and subscription)